Published in J Viral Hepat on May 01, 1998
Hepatocellular carcinoma--cause, treatment and metastasis. World J Gastroenterol (2001) 3.95
Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. Gut (2000) 1.82
Interactions Between GB Virus Type C and HIV. Curr Infect Dis Rep (2002) 0.79
Association between Hepatitis G and Unknown Chronic Hepatitis. Electron Physician (2015) 0.75
Activation of mammalian Chk1 during DNA replication arrest: a role for Chk1 in the intra-S phase checkpoint monitoring replication origin firing. J Cell Biol (2001) 3.35
Mild cervical dyskaryosis: safety of cytological surveillance. Lancet (1992) 3.09
Liver biopsy: blind or guided? BMJ (1994) 2.86
Coronary heart disease in Western Collaborative Group Study. Final follow-up experience of 8 1/2 years. JAMA (1975) 2.84
Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia (2000) 2.84
Identification of polyphosphate-accumulating organisms and design of 16S rRNA-directed probes for their detection and quantitation. Appl Environ Microbiol (2000) 2.57
Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. J Hepatol (2001) 2.43
Prevalence of human papillomavirus type 16 DNA sequences in cervical intraepithelial neoplasia and invasive carcinoma of the cervix. Br J Obstet Gynaecol (1985) 2.28
Persisting mortality in diabetic ketoacidosis. Diabet Med (1993) 2.28
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat (2014) 2.23
Hepatitis C virus infection and liver disease in blood donors. Br J Hosp Med (1994) 2.04
Withdrawing low risk women from cervical screening programmes: mathematical modelling study. BMJ (1999) 2.03
Saphenoperitoneal shunts for patients with intractable ascites associated with chronic liver disease. Br J Surg (1999) 2.02
Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut (2004) 1.93
Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections. J Clin Microbiol (1993) 1.83
Association between MHC class II alleles and clearance of circulating hepatitis C virus. Members of the Trent Hepatitis C Virus Study Group. J Infect Dis (1998) 1.77
TT virus infection in patients with hepatitis C: frequency, persistence, and sequence heterogeneity. J Infect Dis (1999) 1.76
Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Clin Chem (1995) 1.75
Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine. J Hepatol (2000) 1.73
Current views on cervical intraepithelial neoplasia. J Clin Pathol (1991) 1.72
3-Aminopropyltriethoxysilane (APES): a new advance in section adhesion. J Clin Pathol (1987) 1.70
Histological and immunocytochemical study of cervical intraepithelial neoplasia (CIN) with associated HPV 6 and HPV 16 infections. J Clin Pathol (1986) 1.70
Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat (2014) 1.68
Social adjustment after rehabilitation: a two year follow-up of patients with severe head injury. Psychol Med (1980) 1.68
Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat (2014) 1.67
Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change? Lancet (1988) 1.66
Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping. Nature (1989) 1.64
Autoantibodies in chronic hepatitis C virus infection and their association with disease profile. J Viral Hepat (2009) 1.63
The economic and quality-of-life benefits of Helicobacter pylori eradication in chronic duodenal ulcer disease--a community-based study. Postgrad Med J (1995) 1.59
Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK. Br J Cancer (2006) 1.57
Rectal mucosal plasma cells in inflammatory bowel disease. Gut (1983) 1.56
T-lymphocyte populations in normal and coeliac small intestinal mucosa defined by monoclonal antibodies. Gut (1986) 1.56
A review of evaluative studies of computer-based learning in nursing education. Nurse Educ Today (2001) 1.54
Chemical components separation with botulinum toxin A: a novel technique to improve primary fascial closure rates of the open abdomen. Hernia (2012) 1.52
DNA adducts in different tissues of smokers and non-smokers. Int J Cancer (1990) 1.48
HCV and PCR negativity. Lancet (1992) 1.43
Development of a strand-specific RT-PCR based assay to detect the replicative form of hepatitis C virus RNA. J Virol Methods (2001) 1.43
Interferon plus amantadine versus interferon alone in the treatment of naïve patients with chronic hepatitis C: a UK multicentre study. J Hepatol (2001) 1.42
Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection. Eur J Immunol (2001) 1.40
Social adjustment after closed head injury: a further follow-up seven years after injury. J Neurol Neurosurg Psychiatry (1985) 1.39
Current differences in referral patterns for pulmonary endarterectomy in the UK. Eur Respir J (2008) 1.39
Bayesian analysis of pentaquark signals from CLAS data. Phys Rev Lett (2008) 1.39
Evaluation of diagnostic peritoneal lavage in stable patients with gunshot wounds to the abdomen. Arch Surg (1997) 1.38
Cytological status and lesion size: a further dimension in cervical intraepithelial neoplasia. Br J Obstet Gynaecol (1989) 1.38
Measurement of two- and three-nucleon short-range correlation probabilities in nuclei. Phys Rev Lett (2006) 1.37
Resolution of hyperparathyroidism, renal osteodystrophy and metastatic calcification after renal homotransplantation. N Engl J Med (1968) 1.36
Clinical pathways for patients with newly diagnosed hepatitis C - what actually happens. J Viral Hepat (2006) 1.28
Investigations: how to get from guidelines to protocols. BMJ (1991) 1.22
Viruses and cervical cancer. BMJ (1991) 1.21
Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation. J Pathol (1997) 1.21
Gastro-oesophageal candidiasis. Gut (1982) 1.20
The reliability of serological tests for the diagnosis of genital herpes: a critique. Pathology (1993) 1.20
Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis. Br J Surg (1995) 1.20
The effect of lower-extremity position on cerebrospinal fluid pressures. Acad Emerg Med (2001) 1.19
Subpopulations of Langerhans' cells in cervical neoplasia. Br J Obstet Gynaecol (1987) 1.19
Subclinical penile human papillomavirus infection and dysplasia in consorts of women with cervical neoplasia. Genitourin Med (1988) 1.17
Interaction of hepatitis B and hepatitis C infection in haemophilia. Br J Haematol (1993) 1.17
Defining duodenitis: quantitative histological study of mucosal responses and their correlations. J Clin Pathol (1985) 1.17
CIN 3: the role of lesion size in invasion. Br J Obstet Gynaecol (1992) 1.16
Small intestinal plasma cells in coeliac disease. Gut (1984) 1.16
Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa. Gut (2000) 1.15
p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma. Int J Gynecol Pathol (2003) 1.13
Endoscopic small intestinal biopsy. Gastrointest Endosc (1981) 1.13
Methicillin-resistant Staphylococcus aureus on orthopaedic wards: incidence, spread, mortality, cost and control. J Bone Joint Surg Br (2006) 1.11
'Entopy': localized mucosal allergic disease in the absence of systemic responses for atopy. Clin Exp Allergy (2003) 1.11
Definition of human papillomavirus type 16 DNA levels in low and high grade cervical lesions by a simple polymerase chain reaction technique. Arch Virol (1993) 1.10
UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients. Aliment Pharmacol Ther (2012) 1.10
Hepatitis C in blood donors. Lancet (1993) 1.10
Respiratory and facial protection: a critical review of recent literature. J Hosp Infect (2013) 1.09
Secretory carcinoma of the breast in adults: emphasis on late recurrence and metastasis. Histopathology (1989) 1.09
Tuberculosis: the native Indian viewpoint on its prevention, diagnosis, and treatment. Prev Med (1977) 1.07
Post inflammatory damage to the enteric nervous system in diverticular disease and its relationship to symptoms. Neurogastroenterol Motil (2009) 1.06
Muscle metabolism during sprint exercise in man: influence of sprint training. J Sci Med Sport (2004) 1.06
Continuous 5-fluorouracil infusion in refractory carcinoma of the breast. Breast Cancer Res Treat (1987) 1.05
Unique gene expression patterns in liver and kidney associated with exposure to chemical toxicants. J Pharmacol Exp Ther (2001) 1.05
How could pathologists improve the initial diagnosis of colitis? Evidence from an international workshop. J Clin Pathol (2002) 1.05
Cytological screening and management of abnormalities in prevention of cervical cancer: an overview with stochastic modelling. J Clin Pathol (1994) 1.05
Heart rate, blood lactate and kinematic data of elite colts (under-19) rugby union players during competition. J Sports Sci (1998) 1.05
Relationship of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome. J Infect Dis (2001) 1.05
Isoniazid chemoprophylaxis of tuberculosis. Calif Med (1972) 1.05
Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome. Aliment Pharmacol Ther (2003) 1.04
A microcomputer system in the delivery suite. Br J Obstet Gynaecol (1984) 1.04
An investigation of operating theatre staff exposed to humidifier fever antigens. Br J Ind Med (1981) 1.03
TT virus sequence heterogeneity in vivo: evidence for co-infection with multiple genetic types. J Gen Virol (1999) 1.02
Management of squamous atypia (borderline nuclear abnormalities): repeat cytology or colposcopy? Aust N Z J Obstet Gynaecol (1987) 1.01
Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis. J Hepatol (1997) 1.01
Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease. Cell Mol Life Sci (2001) 1.00
ABC of diseases of liver, pancreas, and biliary system: Chronic viral hepatitis. BMJ (2001) 1.00
Intradermal hepatitis B vaccine. Lancet (1987) 0.99
Healing of duodenal ulcer after eradication of Helicobacter heilmannii. Lancet (1997) 0.98
The mildly abnormal cervical smear: patient anxiety and choice of management. J R Soc Med (1996) 0.98
Detection of human papillomavirus DNA sequences by in situ DNA-DNA hybridisation in cervical intraepithelial neoplasia and invasive carcinoma: a retrospective study. J Clin Pathol (1988) 0.98
A new fixed cryosection technique for the simultaneous immunocytochemical demonstration of T6 and S100 antigens. Histochem J (1987) 0.97
Impact of acid secretion, gastritis, and mucus thickness on gastric transfer of antibiotics in rats. Gut (2002) 0.97
Antibody to both human herpesvirus 6 and cytomegalovirus. Lancet (1988) 0.97